These findings confirm the dysregulation of IMRGs in ccRCC, consistent with their roles (apart from DBH, CCR4, CMA1 and ENTPD2) in tumor progression and their inclusion in the prognostic model. This evidence concerns the gene CCR4 and nonpapillary renal cell carcinoma.